Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Terns Pharmaceuticals Inc (NQ: TERN ) 7.630 -0.140 (-1.80%) Streaming Delayed Price Updated: 10:07 AM EDT, Aug 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Terns Pharmaceuticals Inc < Previous 1 2 3 4 5 Next > Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs? July 20, 2024 At least one of the pair has a credible shot at finding a home in the market. Via The Motley Fool EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players' July 18, 2024 Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry. Via Benzinga Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session July 11, 2024 Via Benzinga TERN Stock Earnings: Terns Pharma Meets EPS for Q4 2023 March 14, 2024 TERN stock results show that Terns Pharma met analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Recap: Terns Pharma Q3 Earnings November 14, 2023 Via Benzinga 12 Analysts Have This to Say About Terns Pharma July 26, 2023 Via Benzinga Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday July 11, 2024 Via Benzinga TERN Stock Earnings: Terns Pharma Beats EPS for Q1 2024 May 13, 2024 TERN stock results show that Terns Pharma beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich March 25, 2024 Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session March 21, 2024 Via Benzinga Expert Ratings for Terns Pharma June 22, 2023 Via Benzinga 8 Analysts Have This to Say About Terns Pharma May 31, 2023 Via Benzinga Expert Ratings for Terns Pharma May 08, 2023 Via Benzinga Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? March 17, 2024 Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while. Via The Motley Fool Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session February 09, 2024 Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results. Via Benzinga Top 5 Health Care Stocks That Are Ticking Portfolio Bombs December 05, 2023 As of Dec. 5, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. Via Benzinga Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session December 04, 2023 Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20... Via Benzinga SAIC Reports Q3 Results, Joins Uber, Wallbox And Other Big Stocks Moving Higher On Monday December 04, 2023 U.S. stocks traded lower, with the Dow Jones index falling more than 100 points on Monday. Via Benzinga Topics Stocks Exposures US Equities 3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy? August 23, 2023 NASH treatments are projected to be one of the most sought-after indications in the coming years. Via The Motley Fool Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It August 23, 2023 NASH is a surprisingly common ailment, and the first treatments are on the way. Via The Motley Fool Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday August 10, 2023 Keybanc cut the price target for i3 Verticals, Inc. (NASDAQ: IIIV) from $28 to $26. Keybanc analyst Josh Beck maintained an Overweight rating. i3 Verticals shares fell 2.9% to close at $22.76 on... Via Benzinga Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says June 28, 2023 Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) shares lost more than 25% of their value due to investor pressure it faced after Eli Lilly And Co (NYSE: LLY) announced data from retatrutide that was... Via Benzinga Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 27, 2023 Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 27, 2023 Via Benzinga Terns Pharma Has 35% Upside According To This Analyst, NASH Asset To Drive Valuation June 22, 2023 Mizuho initiated coverage on Terns Pharmaceuticals Inc (NASDAQ: TERN) with a Buying rating and price target of $16, Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023 June 22, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023 June 07, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023 May 31, 2023 Via Benzinga Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 23, 2023 Gainers Via Benzinga Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 16, 2023 Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.